Funder: European Commission
Due Dates: April 13, 2027 (Full application deadline, single-stage)
Funding Amounts: €9,000,000–€10,000,000 per project; 4 projects funded under this topic
Summary: Supports research advancing monoclonal antibody therapies for key emerging and re-emerging viral infections to strengthen EU epidemic preparedness.
Key Information: Applicants must target only one virus per proposal; international collaboration and SME participation are strongly encouraged.